CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 61 filers reported holding CARDIFF ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,041 | -46.0% | 53,267 | -42.9% | 0.00% | – |
| Q2 2023 | $137,051 | +176.9% | 93,232 | +210.8% | 0.00% | – |
| Q1 2023 | $49,500 | +51.7% | 30,000 | +28.7% | 0.00% | – |
| Q4 2022 | $32,633 | +25.5% | 23,309 | +93.9% | 0.00% | – |
| Q2 2022 | $26,000 | -97.8% | 12,019 | -97.4% | 0.00% | -100.0% |
| Q1 2022 | $1,157,000 | -49.0% | 466,347 | +23.6% | 0.00% | -40.0% |
| Q4 2021 | $2,268,000 | -43.7% | 377,369 | -37.6% | 0.01% | -44.4% |
| Q3 2021 | $4,028,000 | -14.5% | 604,750 | -14.7% | 0.01% | -18.2% |
| Q2 2021 | $4,713,000 | -29.8% | 708,668 | -2.2% | 0.01% | -35.3% |
| Q1 2021 | $6,713,000 | +9.9% | 724,959 | +113.4% | 0.02% | -5.6% |
| Q4 2020 | $6,111,000 | – | 339,682 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
| Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
| Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
| Atom Investors LP | 33,798 | $84,000 | 0.04% |
| XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
| Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
| Walleye Capital LLC | 123,305 | $306,000 | 0.01% |